This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_TONSIL_EXALLC for full statistics.
Malignant neoplasm of tonsil
C3_TONSIL
tonsil cancer: Tumors or cancer of the PALATINE TONSIL.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
479 |
4. Check minimum number of eventsNone |
479 |
5. Include endpointsNone |
479 |
6. Filter based on genotype QC (FinnGen only) |
479 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of tonsil
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of oropharynx
- Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)
- Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of head and neck
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 479 | 149 | 330 |
| Unadjusted period prevalence (%) | 0.12 | 0.05 | 0.15 |
| Median age at first event (years) | 61.15 | 61.92 | 60.79 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 447
- Matched controls
- 4472
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8070/3-C09.9
ICD-O-3
Squamous cell carcinoma, NOS, of tonsil, NOS
+∞
268.8
230
*
C09.0
ICD-10 Finland
Malignant neoplasm: Tonsillar fossa
+∞
268.8
230
*
C09.9
ICD-10 Finland
Malignant neoplasm: Tonsil, unspecified
+∞
180.9
161
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
147.0
158.0
161
17
EMB10
NOMESCO Finland
Tonsillectomy
48.1
150.6
184
64
JDB10
NOMESCO Finland
Percutaneous gastrostomy
114.5
139.8
147
19
130
Kela drug reimbursment
Malignant tumour
18.8
133.9
229
236
A03FA01
ATC
metoclopramide; systemic, rectal
13.0
125.4
282
519
C09.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of tonsil
+∞
100.9
93
*
WF002
NOMESCO Finland
Radical radiotherapy
16.5
92.0
158
143
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
28.4
81.0
112
52
EMA10
NOMESCO Finland
Biopsy of tonsil
140.9
77.9
81
7
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
80.3
76.6
85
13
D10.4
ICD-10 Finland
Benign neoplasm: Tonsil
294.7
74.8
74
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
21.6
71.6
108
65
EP1AE
NOMESCO Finland
Neck ultrasound examination
14.2
70.5
127
121
N02AA05
ATC
oxycodone; systemic
7.0
64.8
193
435
A04AA02
ATC
granisetron; systemic, transdermal
12.7
63.4
120
125
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
85.6
60.0
66
9
8070/3-C09.0
ICD-O-3
Squamous cell carcinoma, NOS, of tonsillar fossa
+∞
55.4
52
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
40.5
52.8
66
19
9680/3-C09.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of tonsil, NOS
+∞
51.0
48
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
66.4
50.8
58
10
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
30.1
49.9
67
26
UJC01
NOMESCO Finland
Scopy of lower throat
45.9
49.3
60
15
A04AA01
ATC
ondansetron; systemic, rectal
8.9
49.0
113
164
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
10.6
48.2
99
117
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.5
47.9
254
1015
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
38.3
47.4
60
18
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
12.9
46.7
86
81
H02AB02
ATC
dexamethasone; systemic
7.0
46.0
126
236
ZX095
NOMESCO Finland
Combined chemoradiotherapy
46.1
43.6
53
13
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
21.8
43.3
64
34
R4190
NOMESCO Finland
Nutritional therapy
13.4
42.4
76
67
WF003
NOMESCO Finland
Adjuvant radiotherapy
14.3
42.0
73
60
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
118.6
40.5
43
*
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
40.0
40.0
50
14
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
67.7
37.9
43
7
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
8.0
37.2
90
137
A07AA02
ATC
nystatin; oral
7.9
37.0
90
138
ZX090
NOMESCO Finland
Other technic of radiotherapy
12.5
36.9
68
63
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.6
36.4
263
1263
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
+∞
34.8
33
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
7.7
34.2
84
130
UDH02
NOMESCO Finland
Rhinopharyngoscopy
7.1
33.3
87
147
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
40.8
33.1
41
11
9591/3-C09.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of tonsil, NOS
+∞
32.7
31
*
XX3DW
NOMESCO Finland
Time consuming IT work
5.1
32.6
116
288
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
23.2
32.1
46
22
SAA03
NOMESCO Finland
Extended examination of mouth
3.3
31.5
234
1105
D37.08
ICD-10 Finland
Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx
335.2
31.2
31
*
J35.1
ICD-10 Finland
Hypertrophy of tonsils
38.7
31.1
39
11
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
7.5
30.6
76
119
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
34.5
29.6
38
12
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
6.8
28.5
76
131
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
13.0
28.0
50
43
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
7.7
27.7
67
100
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
36.6
26.9
34
10
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
25.1
26.6
37
16
GBB00
NOMESCO Finland
Tracheostomy
19.3
25.8
39
22
EBA15
NOMESCO Finland
Extraction of large number of teeth
6.8
25.4
67
113
ENB20
NOMESCO Finland
Pharyngectomy
+∞
25.2
24
*
EBA10
NOMESCO Finland
Surgical removal of tooth
4.6
23.8
90
232
ZX070
NOMESCO Finland
Intensity modified radiotherapy
11.2
23.1
44
43
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
7.2
23.1
58
91
WX408
NOMESCO Finland
General anesthesy, balanced
2.9
22.7
185
872
R13
ICD-10 Finland
Dysphagia
5.2
21.5
70
153
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
7.1
21.5
54
85
A04AD12
ATC
aprepitant; systemic
12.5
21.2
38
33
K11.70
ICD-10 Finland
Hypoptyalism
63.2
21.1
24
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
5.0
20.9
71
163
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
8.1
20.2
46
62
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
3.8
19.9
92
284
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
11.1
19.5
37
36
ENA10
NOMESCO Finland
Biopsy of pharynx
48.3
19.4
23
5
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
4.3
19.2
75
198
UJC02
NOMESCO Finland
Rigid oesophagoscopy
22.0
18.8
27
13
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
5.9
18.1
52
98
R07.0
ICD-10 Finland
Pain in throat
5.9
17.7
51
96
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
99.0
17.7
19
*
WZC30
NOMESCO Finland
Teaching
3.2
17.5
103
379
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
9.6
17.2
35
39
JN6AD
NOMESCO Finland
CT of torso and neck
14.0
17.2
29
22
H03AA01
ATC
levothyroxine sodium; systemic
2.9
17.2
122
511
WW500
NOMESCO Finland
Blood transfusion
5.7
16.8
49
94
9673/3-C09.9
ICD-O-3
Mantle cell lymphoma of tonsil, NOS
+∞
16.8
16
*
ENB00
NOMESCO Finland
Excision or exploration of lesion of pharynx
+∞
16.8
16
*
SBB10
NOMESCO Finland
Teeth copy
5.3
16.0
50
104
L03AA02
ATC
filgrastim; parenteral
7.1
16.0
39
59
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
62.3
15.9
18
*
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
27.4
15.7
21
8
SCA04
NOMESCO Finland
Guidance on care of mouth and oral mucosa
33.0
14.9
19
6
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
4.0
14.9
62
173
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
26.1
14.8
20
8
GD1AD
NOMESCO Finland
Thorax CT examination
5.4
14.8
45
91
C09
ICD-10 Finland
Malignant neoplasm of tonsil
+∞
14.7
14
*
EMB00
NOMESCO Finland
Excision of lesion of tonsil or adenoids
+∞
14.7
14
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
14.4
240
1544
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
20.0
14.4
21
11
JN4BD
NOMESCO Finland
Extensive body CT
3.0
14.2
91
352
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.4
13.9
150
784
WX002
NOMESCO Finland
Sedation and analgesia
2.6
13.6
118
547
TJD20
NOMESCO Finland
Change of gastrostomy tube
35.2
13.6
17
5
WX402
NOMESCO Finland
General anaesthesia
2.7
13.2
101
435
ZX120
NOMESCO Finland
Intravenous
3.3
12.8
67
225
A02BC05
ATC
esomeprazole; systemic
2.1
12.8
205
1274
C83.1
ICD-10 Finland
Mantle cell lymphoma
16.0
12.7
20
13
L03AA13
ATC
pegfilgrastim; parenteral
5.9
12.7
35
63
D70.82
ICD-10 Finland
Drug-induced neutropenia
9.1
12.7
26
30
ENB40
NOMESCO Finland
Excision of branchial cyst or fistula
72.0
12.7
14
*
C01
ICD-10 Finland
Malignant neoplasm of base of tongue
72.0
12.7
14
*
T05
ICPC
Feeding problem of adult
33.1
12.6
16
5
K05.31
ICD-10 Finland
Periodontitis pronounced
3.0
12.6
76
283
C09.1
ICD-10 Finland
Malignant neoplasm: Tonsillar pillar (anterior)(posterior)
+∞
12.6
12
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
12.1
12.4
22
19
A06AD11
ATC
lactulose; oral
2.7
12.3
93
398
RD160
NOMESCO Finland
NA
48.0
11.9
14
*
SAA04
NOMESCO Finland
Special inverstigation of mouth
4.4
11.9
43
105
Z43.1
ICD-10 Finland
Attention to gastrostomy
123.1
11.5
12
*
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
10.0
11.4
22
23
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.9
11.1
71
274
EP1BG
NOMESCO Finland
MRI examination of soft tissue of neck with high intesity magnet
44.5
11.0
13
*
Q18.0
ICD-10 Finland
Sinus, fistula and cyst of branchial cleft
44.5
11.0
13
*
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
5.4
10.8
32
63
Z51.5
ICD-10 Finland
Palliative care
3.6
10.7
48
143
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
8.8
10.7
22
26
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
4.1
10.6
41
107
SCA03
NOMESCO Finland
Preventive oral health care, extensive
4.7
10.5
35
79
ENB99
NOMESCO Finland
Other excision of pharynx and adjacent structures
112.6
10.5
11
*
EB1BA
NOMESCO Finland
Extensive intraoral X-ray examination
24.0
10.3
14
6
WX110
NOMESCO Finland
Local anesthesy
2.0
10.1
309
2376
EB1WA
NOMESCO Finland
NA
11.7
10.1
18
16
J02AC01
ATC
fluconazole; systemic
2.1
10.1
150
882
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
10.4
10.1
19
19
RD210
NOMESCO Finland
NA
7.9
10.0
22
29
XW000
NOMESCO Finland
Bone marrow biopsy
3.9
9.8
40
110
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.2
9.7
25
42
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
11.7
9.6
17
15
UDQ22
NOMESCO Finland
Microlaryngoscopy
11.7
9.6
17
15
A04AA55
ATC
palonosetron, combinations; systemic
5.6
9.5
27
51
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
18.0
9.5
14
8
EP1CM
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with 3 Tesla magnet
102.1
9.4
10
*
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.9
9.4
59
224
UJC20
NOMESCO Finland
Extensive endoscopy to identify diagnosed or suspected primary malignant neoplasm of head or neck
+∞
9.4
9
*
8085/3-C09.9
ICD-O-3
Squamous cell carcinoma, HPV positive of tonsil, NOS
+∞
9.4
9
*
1460A
ICD-9 Finland
Malignant neoplasm of oropharynx, Tonsil
+∞
9.4
9
*
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
14.1
9.2
15
11
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
4.0
9.2
36
96
SXC03
NOMESCO Finland
Other oral or dental procedure
9.3
9.1
18
20
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.9
9.0
56
211
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
4.7
9.0
30
68
EBA12
NOMESCO Finland
Complicated surgical removal of tooth
7.1
8.9
21
31
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
5.0
8.7
27
57
K05.30
ICD-10 Finland
Periodontitis complex
2.4
8.7
75
343
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
7.6
8.5
19
26
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
6.9
8.5
20
30
J35.9
ICD-10 Finland
Chronic disease of tonsils and adenoids, unspecified
91.7
8.4
9
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
8.3
146
902
SBA00
NOMESCO Finland
Microbiological examinations
5.3
8.3
24
47
N05CF01
ATC
zopiclone; oral
1.9
8.2
148
923
N02AJ06
ATC
codeine and paracetamol; systemic
1.8
8.2
174
1147
WW300
NOMESCO Finland
Transfer of autologic stem cells
17.6
8.1
12
7
D37.09
ICD-10 Finland
Lip, oral cavity and pharynx
34.0
8.1
10
*
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
13.3
7.9
13
10
UDQ02
NOMESCO Finland
Direct laryngoscopy
11.1
7.8
14
13
K02.1
ICD-10 Finland
Caries of dentine
1.8
7.8
244
1816
R4130
NOMESCO Finland
Speech therapy
6.1
7.8
20
34
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
3.4
7.8
37
117
JN4DR
NOMESCO Finland
Whole body metabolic PET with CT
25.5
7.6
10
*
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
9.1
7.6
15
17
EBA00
NOMESCO Finland
Extraction of tooth
1.8
7.6
153
987
WX199
NOMESCO Finland
Other local analgesia
5.0
7.6
23
48
A02BC02
ATC
pantoprazole; systemic
1.8
7.5
294
2328
K10.26
ICD-10 Finland
Periostitis of jaw (acute)(chronic)(suppurative)
81.4
7.4
8
*
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
3.2
7.4
38
127
PJA10
NOMESCO Finland
Exploration of lymph nodes
7.0
7.4
17
25
R04.1
ICD-10 Finland
Haemorrhage from throat
+∞
7.3
7
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
7.3
107
614
K12.10
ICD-10 Finland
Stomatitis NOS
30.5
7.2
9
*
XQ902
NOMESCO Finland
Other photography
20.4
7.2
10
5
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
12.3
7.1
12
10
SBA10
NOMESCO Finland
Measurement of excretion of saliva
12.3
7.1
12
10
K11.2
ICD-10 Finland
Sialoadenitis
4.6
7.1
23
52
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
7.7
7.0
15
20
EBB15
NOMESCO Finland
Insertion of dental implant abutment
9.5
6.8
13
14
UGC02
NOMESCO Finland
Rigid bronchoscopy
40.7
6.8
8
*
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
17.0
6.8
10
6
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
5.1
6.7
20
41
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
22.9
6.7
9
*
K03.28
ICD-10 Finland
Other erosion of teeth
8.0
6.7
14
18
SDA02
NOMESCO Finland
Parodonthologic therapy
1.8
6.6
137
885
ED1AA
NOMESCO Finland
Mandipular X-ray examination
7.6
6.5
14
19
D10.9
ICD-10 Finland
Benign neoplasm: Pharynx, unspecified
70.8
6.4
7
*
R11
ICD-10 Finland
Nausea and vomiting
2.9
6.4
37
134
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
6.3
98
572
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
18.3
6.3
9
5
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
18.3
6.3
9
5
EP1DM
NOMESCO Finland
Very extensive MRI examination of soft tissue of neck with 3 Tesla magnet
+∞
6.3
6
*
8072/3-C09.9
ICD-O-3
Squamous cell carcinoma, large cell, nonkeratinizing, NOS, of tonsil, NOS
+∞
6.3
6
*
8083/3-C09.9
ICD-O-3
Basaloid squamous cell carcinoma of tonsil, NOS
+∞
6.3
6
*
9691/3-C09.9
ICD-O-3
Follicular lymphoma, grade 2 of tonsil, NOS
+∞
6.3
6
*
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.8
6.2
110
676
J01CE02
ATC
phenoxymethylpenicillin; oral
1.7
6.1
289
2344
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
12.7
6.1
10
8
H02AB06
ATC
prednisolone; systemic
1.6
6.1
202
1491
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
221
370
10.23
140.78
1.5
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
94
96
11.94
84.75
1.4
1.3
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
93
117
9.62
71.58
3.5
2.8
mg/l
1.1
1.6
6.57
93
107
(3012095) Magnesium [Moles/volume] in Serum or Plasma
222
704
5.01
66.25
7.8
3.4
mmol/l
0.8
0.8
8.37
215
662
(40768804) Tissue Pathology biopsy report
300
1509
3.64
41.57
2.4
2.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
37
28
14.24
39.52
1.1
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
39
42
10.02
33.12
1.2
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
364
2274
3.50
31.69
15.0
9.7
e9/l
4.0
4.2
0.78
340
2004
(3015377) Calcium [Moles/volume] in Serum or Plasma
253
1347
2.86
28.17
6.0
3.6
mmol/l
2.4
2.3
2.28
238
1173
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
329
2195
2.59
20.68
9.8
6.9
umol/l
10.3
12.2
4.87
324
2086
(40758558) Short blood count panel - Blood
190
992
2.52
20.37
11.3
6.9
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
285
1814
2.41
19.33
6.3
5.2
g/l
35.3
35.3
0.03
271
1685
(42870588) Differential panel, method unspecified - Blood
228
1348
2.32
17.92
6.2
5.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
71
238
3.33
17.29
1.3
1.5
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
276
1811
2.24
16.37
7.3
5.9
%
0.7
0.7
0.14
263
1702
(3006504) Eosinophils/100 leukocytes in Blood
280
1856
2.22
16.08
7.4
6.0
%
2.8
2.9
0.46
267
1737
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
283
1901
2.19
15.50
4.7
4.3
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
279
1865
2.19
15.45
7.7
6.3
%
9.6
9.0
1.62
267
1757
(3026389) Candida sp identified in Specimen by Organism specific culture
24
37
6.78
15.06
1.3
1.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
281
1898
2.16
14.97
7.6
6.2
%
24.2
26.9
3.09
266
1780
(3001604) Monocytes [#/volume] in Blood
289
1976
2.17
14.89
7.1
5.8
e9/l
0.6
0.6
0.05
264
1714
(3006315) Basophils [#/volume] in Blood
289
1986
2.15
14.56
7.2
5.8
e9/l
0.0
0.0
0.51
264
1731
(3018010) Neutrophils/100 leukocytes in Blood
276
1871
2.12
14.32
7.3
6.0
%
59.4
57.6
1.53
262
1761
(3013115) Eosinophils [#/volume] in Blood
294
2046
2.13
14.17
7.7
6.0
e9/l
0.2
0.2
1.96
269
1817
(3019198) Lymphocytes [#/volume] in Blood
291
2018
2.13
14.15
7.4
5.9
e9/l
1.7
1.9
0.96
268
1790
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
398
3138
2.59
14.06
12.2
8.2
u/l
80.2
79.9
0.04
385
2947
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
33
76
4.59
13.55
1.4
2.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
263
1792
2.04
12.98
8.8
9.4
inr
1.2
1.3
0.33
86
501
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
141
772
2.17
12.48
5.1
3.3
mmol/l
2.5
2.5
1.55
132
676
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38
108
3.74
11.82
1.4
1.9
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
284
2030
1.98
11.78
8.1
7.1
mmol/l
1.2
1.2
0.39
233
1733
(3044640) Blood type and Crossmatch panel - Blood
204
1322
1.95
11.11
3.1
2.7
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
12
11
11.16
11.10
1.5
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
37
108
3.63
11.07
1.4
1.9
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
108
565
2.18
10.53
5.4
5.9
mmol/l
1.0
1.0
1.11
98
525
(21494814) CD8 cells/100 lymphocytes in Specimen
12
12
10.23
10.48
1.5
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
248
1743
1.88
10.31
12.0
10.2
e9/l
0.0
0.0
0.35
221
1441
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
85
406
2.33
10.30
1.3
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
82
387
2.35
10.21
1.3
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
191
1238
1.90
10.18
5.8
4.4
—
—
—
0
0
(3002256) Pathology report gross observation
102
529
2.18
10.14
1.4
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
25
61
4.27
9.55
1.4
1.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
94
488
2.15
9.26
1.4
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
169
1081
1.87
9.19
1.4
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
257
1873
1.80
9.08
7.4
6.3
mmol/l
1.2
1.2
0.06
238
1700
(46235355) HIV 1 and 2 tests - Meaningful Use set
93
485
2.14
9.05
1.5
1.6
—
—
—
0
0
(44790047)
22
52
4.39
8.75
1.5
1.8
—
—
—
0
0
(44806118)
22
52
4.39
8.75
1.5
1.8
—
—
—
0
0
(44790049)
22
52
4.39
8.75
1.5
1.8
—
—
—
0
0
(44790048)
22
52
4.39
8.75
1.5
1.8
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
12
16
7.67
8.45
1.3
1.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
317
2491
1.81
8.39
5.8
5.1
mmol/l
6.4
6.8
4.37
300
2342
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
20
46
4.49
8.22
1.3
2.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
14
25
5.74
7.58
1.8
2.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
91
508
1.98
7.28
2.1
1.7
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
15
30
5.13
7.23
1.7
1.7
—
32.4
—
0
5
(3021440) Promyelocytes/100 leukocytes in Blood
65
328
2.14
6.81
5.2
4.7
%
0.1
0.1
0.20
30
105
(3011412) CD3 cells [#/volume] in Blood
17
40
4.37
6.80
1.9
2.0
e9/l
1.4
1.0
0.50
12
21
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
341
2820
1.73
6.69
5.3
3.5
pmol/l
14.6
14.9
1.47
319
2524
(3017181) Myelocytes/100 leukocytes in Blood
68
354
2.07
6.57
5.3
4.6
%
1.2
0.7
0.72
32
116
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
13
25
5.32
6.52
1.8
2.0
—
18.3
—
0
12
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
26
86
3.14
6.44
1.3
1.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
68
358
2.05
6.37
8.5
9.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
150
1014
1.70
6.35
2.8
2.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
129
838
1.74
6.30
7.4
5.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
42
183
2.42
6.21
1.1
1.2
iu/ml
53.9
148.9
1.42
11
65
(3018418) pH of Serum or Plasma
170
1200
1.65
6.04
5.3
4.2
ph
7.4
7.4
0.20
46
236
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
59
301
2.10
6.01
1.8
1.6
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
13
27
4.92
6.00
4.0
3.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
19
54
3.62
5.94
1.5
2.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
20
60
3.44
5.78
1.4
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
17
46
3.79
5.69
1.4
1.9
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
21
66
3.28
5.66
1.3
1.8
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
18
51
3.63
5.65
1.6
2.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
59
308
2.04
5.65
5.4
4.8
%
0.0
0.1
0.66
23
89
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
10
17
5.99
5.65
3.2
3.2
u/l
178.3
210.5
—
10
17
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
62
336
1.97
5.36
4.7
4.1
mmol/l
1.2
1.2
0.82
57
301
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
29
114
2.64
5.31
1.4
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
86
520
1.80
5.31
1.5
1.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
433
3933
2.05
5.22
24.8
15.6
mg/l
24.9
26.4
0.39
398
3145
(3002179) Metamyelocytes/100 leukocytes in Blood
58
316
1.95
4.94
4.7
4.5
%
0.6
0.3
0.80
19
82
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
21
73
2.96
4.82
1.3
1.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
21
76
2.84
4.51
1.3
1.8
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
61
354
1.83
4.29
3.3
2.0
nmol/l
390.5
363.4
0.46
56
324
(3002385) Erythrocyte distribution width [Ratio]
367
3234
1.58
4.26
29.4
19.2
%
13.9
13.8
1.23
362
3171
(3027945) Reticulocytes/100 erythrocytes in Blood
81
512
1.70
4.26
4.0
2.7
%
1.7
1.8
0.47
72
466
(3013707) Erythrocyte sedimentation rate by Westergren method
337
2922
1.52
4.14
5.0
4.1
mm/h
14.6
12.5
1.56
309
2676
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
20
74
2.78
4.14
4.5
3.3
%
60.1
56.5
0.47
20
74
(3042111) Morphology [Interpretation] in Bone marrow Narrative
22
86
2.63
4.11
2.0
2.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
155
1157
1.50
4.02
4.2
2.8
umol/l
3017.2
7753.8
0.87
138
997
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
14
43
3.32
3.93
1.6
1.9
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
14
43
3.32
3.93
1.6
1.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
14
43
3.32
3.93
1.6
1.9
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
446
4173
2.00
3.72
26.2
18.2
mmol/l
139.0
139.7
4.15
437
4070
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
10
25
4.06
3.71
1.2
2.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
10
25
4.06
3.71
1.2
2.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
73
468
1.66
3.63
1.9
2.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
70
446
1.67
3.57
4.1
3.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
54
320
1.77
3.56
2.3
2.7
ml/min/173m2
60.1
63.8
0.33
18
133
(3005719) IgG [Mass/volume] in Serum or Plasma
55
330
1.75
3.48
3.4
2.7
g/l
9.0
11.0
2.60
49
296
(3023103) Potassium [Moles/volume] in Serum or Plasma
446
4188
1.94
3.44
26.6
18.3
mmol/l
4.0
4.0
2.50
437
4082
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
366
3974
0.67
3.38
4.2
4.7
mmol/l
1.4
1.4
0.92
326
3648
(3048929) Epstein Barr virus Ab [Presence] in Serum
24
109
2.27
3.31
1.3
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
353
3856
0.68
3.30
3.9
4.2
mmol/l
1.3
1.3
0.80
312
3531
(3030905) Polymorphonuclear cells [#/volume] in Blood
18
72
2.56
3.25
4.2
2.8
e9/l
5.1
4.3
0.27
18
72
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
95
668
1.53
3.21
2.1
2.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
11
33
3.39
3.21
1.2
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
70
461
1.61
3.14
1.8
2.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
44
256
1.79
3.10
1.5
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
106
1412
0.68
3.07
3.1
4.0
mg/mmol
6.8
8.3
0.27
61
916
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
8
16
5.07
3.06
3.0
2.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
60
383
1.65
3.05
3.3
3.6
mmol/l
3.2
2.1
1.31
51
307
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
20
87
2.36
3.05
1.2
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
100
1331
0.69
2.84
2.6
3.2
mg/l
39.0
195.9
1.27
59
889
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
16
65
2.51
2.82
1.1
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
329
2933
1.39
2.79
4.1
4.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
31
3.27
2.78
1.2
1.9
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
37
212
1.81
2.76
1.5
1.3
—
—
—
0
0
(3026782) Osmolality of Urine
113
849
1.43
2.72
3.2
2.8
mosm/kgh2o
536.3
576.2
1.08
95
729
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
351
3805
0.71
2.70
5.1
6.3
mmol/mol
38.9
40.5
2.68
328
3518
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
17
73
2.38
2.68
1.1
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
17
73
2.38
2.68
1.1
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
408
3791
1.51
2.67
22.9
14.4
ml/min/173m2
81.4
79.0
1.93
370
3154
(3035637) Corticotropin [Mass/volume] in Plasma
10
32
3.17
2.66
1.5
1.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
294
2588
1.35
2.62
4.4
4.3
e6/l
224.3
2744.4
—
6
44
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
13
50
2.64
2.55
4.0
2.7
nmol/l
2.8
6.3
0.55
13
50
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
10
33
3.07
2.54
1.2
1.9
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
106
1371
0.71
2.52
2.5
3.1
mmol/l
8.3
8.1
0.09
84
1143
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
384
3538
1.43
2.51
6.1
4.3
mu/l
2.7
2.3
0.47
360
3194
(3024869) Neuronal Ab [Presence] in Serum
5
8
6.30
2.37
1.0
1.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
22
3.68
2.37
1.3
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
7
17
4.16
2.36
1.0
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
93
692
1.43
2.35
3.1
3.1
e6/l
1.8
1.2
0.44
55
396
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
375
3994
0.72
2.24
4.3
4.8
mmol/l
4.7
4.5
2.04
340
3691
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
10
5.04
2.07
2.0
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
15
69
2.21
2.06
2.3
2.9
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
381
3543
1.37
2.05
25.0
16.6
%
38.4
40.1
2.61
275
2436
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
11
44
2.54
2.02
3.0
2.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
22
119
1.89
2.00
1.4
1.6
ug/g
218.6
272.1
—
9
72
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
385
4068
0.73
1.98
4.7
5.3
mmol/l
2.8
2.7
1.06
344
3729
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
443
4241
1.59
1.96
15.4
11.1
u/l
26.1
27.9
1.61
429
4095
(40761536) Microorganisms panel - Urine sediment
47
317
1.54
1.95
4.0
3.8
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
52
0.00
1.89
0.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
52
0.00
1.89
0.0
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
6
17
3.56
1.84
1.8
10.9
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
54
383
1.46
1.78
5.0
2.7
e9/l
69.5
71.5
0.14
47
302
(3016650) Hepatitis A virus Ab [Presence] in Serum
14
67
2.12
1.77
1.1
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
101
799
1.33
1.76
3.7
3.8
ng/l
752.0
397.4
0.27
85
660
(3037467) Urinalysis macro (dipstick) panel - Urine
299
2715
1.27
1.75
4.4
4.2
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
6
19
3.18
1.66
3.7
3.7
nmol/l
124.2
78.8
—
6
19
(3006462) Nitrate [Presence] in Urine
6
19
3.18
1.66
2.3
3.8
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
122
999
1.30
1.66
2.1
2.1
mg/l
2.6
3.0
1.15
101
862
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
77
591
1.36
1.64
2.0
2.4
%
22.4
23.8
0.27
69
511
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
13
63
2.09
1.61
1.2
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
32
2.52
1.60
1.0
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
54
392
1.43
1.59
3.2
2.6
u/l
28.2
46.9
0.95
45
335
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
26
2.72
1.58
3.6
1.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
29
184
1.61
1.58
2.0
3.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
171
1470
1.25
1.56
4.2
3.8
e6/l
90.5
103.0
0.10
126
1088
(4034850)
6
140
0.42
1.54
7.5
10.8
—
—
—
0
0
(4211845)
6
21
2.88
1.51
2.2
3.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
93
744
1.31
1.50
3.1
2.9
e6/l
0.9
1.0
0.16
55
443
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
110
1323
0.78
1.48
3.1
3.0
ug/l
0.7
0.7
0.89
74
869
(3024928) Oxygen saturation in Venous blood
16
87
1.87
1.47
1.3
2.9
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
70
540
1.35
1.45
9.6
8.3
kpa
12.4
12.0
0.31
65
516
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
70
540
1.35
1.45
9.6
8.3
kpa
5.2
5.1
0.31
65
512
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
16
3.15
1.44
2.8
5.3
—
—
—
0
0
(3019225) pH of Specimen
54
401
1.39
1.42
3.9
4.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
19
111
1.74
1.41
1.2
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
9
41
2.22
1.37
2.7
1.3
nmol/l
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
19
112
1.73
1.37
1.2
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
19
112
1.73
1.37
1.2
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
6
23
2.63
1.37
1.3
1.2
nmol/l
98.0
140.5
—
6
23
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
23
2.63
1.37
1.3
2.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
23
2.63
1.37
1.3
2.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
17
2.96
1.36
1.0
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
10
195
0.50
1.36
1.2
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
69
538
1.33
1.34
9.8
8.4
mmol/l
1.6
1.0
0.71
60
434
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
9
42
2.16
1.34
1.1
1.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
78
620
1.31
1.33
2.0
2.4
g/l
2.3
2.3
0.14
73
573
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
20
121
1.68
1.33
1.5
2.1
%
83.0
86.5
0.26
20
114
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
21
129
1.66
1.32
1.6
1.6
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
170
1484
1.23
1.32
2.2
2.2
nmol/l
79.3
76.7
0.46
154
1295
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
24
2.52
1.30
1.3
2.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
6
135
0.44
1.29
1.2
1.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
150
1296
1.23
1.28
3.8
3.3
e6/l
89.9
117.0
0.13
123
1017
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
9
44
2.07
1.27
2.2
2.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
35
2.31
1.27
1.0
1.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
159
1808
0.82
1.25
4.0
4.2
%
21.0
20.7
0.10
70
852
(40761511) CBC panel - Blood by Automated count
428
4124
1.36
1.25
20.3
14.9
—
—
—
0
0
(4281824)
8
36
2.24
1.24
1.3
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
25
2.42
1.24
1.3
2.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
25
2.42
1.24
1.3
2.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
25
2.42
1.24
1.3
2.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
25
2.42
1.24
1.3
2.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
42
307
1.40
1.22
3.0
2.4
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
63
492
1.32
1.22
10.0
8.7
%
95.1
95.6
0.18
58
472
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
42
563
0.72
1.22
4.3
4.7
%
32.2
31.0
0.26
32
388
(36304419) Bacteria [Presence] in Urine
133
1140
1.23
1.22
3.5
3.2
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
439
4250
1.39
1.21
28.8
18.5
umol/l
80.0
82.3
1.19
439
4250
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
13
71
1.85
1.20
4.8
5.6
mg/l
10.0
11.0
0.34
13
65
(3030467) Casts [#/volume] in Urine by Automated count
139
1199
1.22
1.20
3.6
3.2
e6/l
0.2
0.5
2.30
110
917
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
36
258
1.43
1.17
12.8
11.1
—
—
—
0
0
(3017704) Immunofixation for Urine
0
34
0.00
1.16
0.0
1.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
15
88
1.73
1.12
2.2
2.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
205
2255
0.84
1.09
4.2
4.9
ug/l
2.1
2.4
0.42
175
2022
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
152
1337
1.20
1.07
4.3
3.6
u/l
98.9
33.6
0.51
145
1271
(3042936) Bacteria identified in Isolate by Culture
82
677
1.25
1.06
2.1
2.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
18
275
0.64
1.05
1.9
2.5
—
12.4
—
0
10
(3013512) EKG study
148
1301
1.20
1.04
4.6
4.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
22
2.29
1.03
1.2
2.4
u/ml
698.6
2044.1
—
5
22
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
9
47
1.93
1.02
2.7
1.3
nmol/l
0.5
0.6
—
9
42
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
14
83
1.71
1.02
1.1
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
187
1683
1.18
1.01
2.0
2.0
pmol/l
95.3
93.5
0.21
91
906
(3022948) Iron [Moles/volume] in Serum or Plasma
81
672
1.25
1.00
2.2
2.4
umol/l
12.1
13.2
0.70
73
622
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
30
409
0.72
0.99
1.5
1.5
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
5
23
2.19
0.98
1.4
1.3
u/l
33.9
43.2
—
5
17
(4027681)
5
23
2.19
0.98
1.4
1.1
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
0
29
0.00
0.98
0.0
1.0
—
0.4
—
0
5
(3014271) Vancomycin [Susceptibility]
0
30
0.00
0.97
0.0
2.6
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
448
4371
1.39
0.97
34.3
22.8
e9/l
242.4
240.3
0.22
440
4252
(3024731) MCV [Entitic volume]
448
4371
1.39
0.97
34.2
22.7
fl
91.8
91.4
0.94
442
4301
(40768806) Pleura Pathology biopsy report
10
54
1.87
0.97
1.2
1.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
9
50
1.82
0.97
1.0
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
105
900
1.21
0.96
3.3
3.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
32
234
1.39
0.96
1.3
1.3
—
—
—
0
0
(3035941) MCH [Entitic mass]
448
4372
1.38
0.96
34.2
22.6
pg
30.6
30.5
0.26
442
4302
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
28
200
1.42
0.96
2.7
2.2
g/l
1.3
1.5
0.59
23
172
(3003338) MCHC [Mass/volume]
344
3265
1.19
0.95
29.9
20.1
g/l
332.9
333.4
0.49
336
3246
(3010813) Leukocytes [#/volume] in Blood
448
4373
1.38
0.95
34.4
22.8
e9/l
6.5
6.7
0.68
439
4241
(3026361) Erythrocytes [#/volume] in Blood
448
4373
1.38
0.95
34.3
22.7
e12/l
4.3
4.5
13.22
439
4239
(3022621) pH of Urine by Test strip
35
261
1.37
0.94
2.3
2.4
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
448
4375
1.37
0.92
34.5
22.9
g/l
130.7
137.4
15.05
442
4305
(3000850) Epithelial cells [#/volume] in Urine
103
889
1.20
0.88
2.9
2.6
e6/l
3.7
3.7
0.02
88
788
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
172
1552
1.17
0.88
3.6
3.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
43
1.87
0.87
2.9
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
35
265
1.35
0.87
1.1
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
30
2.01
0.87
1.0
1.3
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
17
112
1.54
0.86
1.7
2.2
%
198.7
203.7
0.07
17
106
(3019230) Fractional oxyhemoglobin in Venous blood
12
72
1.68
0.86
1.4
2.1
%
68.0
64.6
0.17
12
72
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
21
296
0.70
0.85
1.4
1.8
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
6
31
1.95
0.84
1.0
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
6
31
1.95
0.84
2.7
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
8
45
1.79
0.84
1.1
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
31
232
1.36
0.83
1.2
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
17
113
1.52
0.83
2.9
1.7
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
17
248
0.67
0.83
1.1
1.3
—
46.0
—
0
14
(3011648) Oxygen content in Venous blood
6
32
1.89
0.82
1.7
1.8
%
10.5
11.4
—
6
32
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
58
1.74
0.80
4.3
4.1
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
1.8
—
1.1
—
0
19
(21494755) Public health laboratory ask at order entry panel
23
313
0.72
0.78
1.3
1.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
27
0.00
0.77
0.0
1.0
—
6.7
—
0
9
(40768441) Liver Pathology biopsy report
0
28
0.00
0.76
0.0
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
58
480
1.24
0.76
3.4
4.6
ug/l
35.4
27.8
0.10
47
398
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
8
134
0.59
0.74
1.1
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
57
1.59
0.71
1.0
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
279
2638
1.14
0.70
3.5
3.4
u/l
61.0
56.9
0.23
263
2446
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
26
196
1.35
0.69
5.5
6.2
%
1.6
1.6
0.07
21
183
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
11
69
1.61
0.69
1.3
1.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
29
1.73
0.64
3.2
2.0
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
206
1922
1.13
0.62
4.1
3.5
estimate
0.0
0.0
0.00
43
335
(3003434) Protein [Mass/volume] in Pleural fluid
10
63
1.60
0.62
1.3
1.5
g/l
37.7
30.9
—
10
53
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
38
308
1.25
0.62
1.6
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
43
518
0.81
0.61
11.5
7.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
17
122
1.41
0.61
3.4
1.7
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
17
122
1.41
0.61
1.4
1.2
—
2.5
—
0
11
(3051611) Lipemic interference index of Serum or Plasma
8
51
1.58
0.60
5.5
3.7
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
36
291
1.26
0.60
2.8
3.8
ng/l
93.5
84.1
0.28
31
254
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
32
255
1.27
0.60
1.6
1.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
53
1.52
0.58
5.1
3.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
203
1900
1.12
0.57
5.5
4.8
estimate
0.0
0.0
0.00
44
360
(3000093) Morphology [Interpretation] in Blood Narrative
6
36
1.67
0.57
1.5
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
37
303
1.24
0.56
4.6
5.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
76
861
0.86
0.56
1.5
1.8
pmol/l
468.9
5579216.3
0.50
58
717
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
6
37
1.63
0.55
1.0
1.3
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
12
82
1.48
0.55
1.2
1.1
u/ml
304.3
320.9
—
7
44
(3023410) Appearance of Cerebral spinal fluid
6
38
1.59
0.54
1.5
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
6
38
1.59
0.54
6.2
3.9
—
—
—
0
0
(40768443) Skin Pathology biopsy report
22
169
1.32
0.54
1.0
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
11
74
1.50
0.54
1.5
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
21
161
1.32
0.52
1.2
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
79
701
1.15
0.51
2.0
1.4
g/l
2.4
2.9
1.00
47
425
(1761868) Lipid panel - Serum or Plasma
131
1421
0.89
0.50
2.7
3.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
27
216
1.26
0.50
4.8
3.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
45
1.56
0.49
1.1
1.3
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
13
93
1.41
0.48
1.5
1.2
u/ml
1.9
2.5
—
5
16
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
7
48
1.46
0.47
1.0
1.2
%
124.6
108.7
—
7
43
(3019309) Folate [Moles/volume] in Red Blood Cells
86
774
1.14
0.47
1.8
1.8
nmol/l
1159.6
1187.5
0.09
60
601
(40768797) Stomach Pathology biopsy report
62
545
1.16
0.46
1.2
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
17
129
1.33
0.46
5.2
3.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
93
842
1.13
0.46
1.7
1.7
mg/l
1.5
1.3
0.20
75
644
(3021788) Differential panel - Synovial fluid
5
82
0.61
0.46
1.0
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
20
157
1.29
0.44
1.3
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
14
104
1.36
0.43
1.4
1.6
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
16
122
1.32
0.43
1.7
2.6
g/l
3.7
3.8
0.13
16
116
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
67
749
0.88
0.42
1.2
1.2
u/ml
0.7
1.5
1.74
12
208
(3004119) Hemoglobin [Mass/volume] in Venous blood
32
268
1.21
0.42
3.3
3.2
g/l
129.1
128.5
0.05
32
263
(3020874) Milk IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
0.4
—
0
5
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
16
0.00
0.41
0.0
7.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
201
1909
1.09
0.40
4.0
3.5
estimate
0.0
0.0
0.00
44
349
(3029075) Extractable nuclear Ab panel - Serum
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
0
19
0.00
0.39
0.0
1.1
—
35.8
—
0
11
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.0
—
7.2
—
0
8
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
106
1146
0.90
0.39
1.6
1.7
mmol/l
1.4
1.4
0.11
93
960
(3029937) Albumin [Presence] in Urine by Test strip
113
1048
1.10
0.38
4.4
3.7
estimate
0.0
0.0
0.50
40
336
(3008898) HLA-B27 [Presence]
8
112
0.71
0.37
1.0
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
78
855
0.90
0.37
4.1
3.7
kg/l
1.0
1.0
—
10
125
(3001122) Ferritin [Mass/volume] in Serum or Plasma
162
1532
1.09
0.35
2.7
2.6
ug/l
241.6
171.7
1.45
147
1393
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
43
1.40
0.35
1.2
2.7
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
43
1.40
0.35
1.2
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
21
172
1.23
0.35
2.0
1.7
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
73
1.38
0.34
1.1
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
24
201
1.20
0.33
2.3
2.4
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
17
137
1.25
0.32
7.6
8.1
mmol/l
1.0
1.3
1.39
12
119
(40767503) Oxygen content in Capillary blood by calculation
12
92
1.31
0.32
2.9
2.7
%
14.6
16.2
—
6
48
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
39
343
1.15
0.31
2.9
3.0
ng/l
260.8
193.1
0.51
33
306
(3026008) Bacteria identified in Urine by Culture
118
1107
1.09
0.31
3.6
3.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
7
54
1.30
0.30
1.0
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
31
269
1.16
0.30
1.9
2.8
e9/l
4.4
4.1
0.21
25
210
(40768800) Prostate Pathology biopsy report
12
151
0.79
0.28
1.3
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
123
1298
0.93
0.27
3.5
3.1
ng/l
1186.0
1233.2
0.08
107
1110
(40761535) Cells panel - Urine sediment
32
361
0.88
0.25
3.4
3.2
—
—
—
0
0
(4094501)
14
114
1.23
0.25
1.1
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
14
114
1.23
0.25
3.2
4.0
—
—
—
0
0
(3020891) Body temperature
15
180
0.83
0.24
4.0
4.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
85
0.70
0.24
1.7
3.2
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
13
158
0.82
0.24
1.2
1.8
nmol/l
58.8
40.6
0.93
13
151
(3037756) Immunofixation for Serum or Plasma
13
106
1.23
0.23
2.2
1.7
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
399
3940
1.08
0.21
4.6
4.9
mmol/l
5.9
6.1
2.99
372
3585
(1002224) Polysomnography panel
13
156
0.83
0.21
1.2
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
0.5
—
0
6
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
11
0.00
0.21
0.0
2.2
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(4133840)
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
11
0.00
0.21
0.0
3.6
—
7105.6
—
0
11
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.1
—
0.9
—
0
5
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
8
103
0.77
0.21
1.8
1.5
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.9
—
6.3
—
0
12
(3042733) HLA Ab [Presence] in Serum
0
12
0.00
0.21
0.0
5.9
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
12
0.00
0.21
0.0
7.7
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
43
1.16
0.21
1.0
1.2
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
0
13
0.00
0.21
0.0
1.1
—
14.1
—
0
7
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
13
0.00
0.21
0.0
2.2
—
9.9
—
0
8
(3021901) Oxygen saturation in Capillary blood
10
80
1.26
0.20
3.7
2.5
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
12
99
1.22
0.20
1.1
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
6
50
1.20
0.20
1.0
2.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
175
0.85
0.19
5.1
1.8
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
175
0.85
0.19
5.1
1.8
g/l
3.1
3.8
—
10
128
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
81
1.24
0.19
1.1
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
174
1685
1.05
0.19
4.3
3.9
ng/l
29.4
44.8
1.13
141
1265
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
17
147
1.16
0.18
1.8
1.6
—
132.0
—
0
5
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
19
166
1.15
0.18
2.2
2.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
58
619
0.93
0.18
1.3
1.3
iu/ml
26.5
42.6
0.67
21
194
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
55
587
0.93
0.17
1.2
1.3
u/ml
5.1
13.6
0.98
15
225
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
19
215
0.88
0.17
1.6
1.7
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
8
68
1.18
0.16
1.0
1.1
g/l
1.5
1.6
—
8
59
(3021960) Folate [Moles/volume] in Serum or Plasma
104
997
1.06
0.16
1.6
1.6
nmol/l
22.5
20.5
0.71
91
839
(3000764) Benzodiazepines [Presence] in Urine
8
72
1.11
0.16
2.3
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
8
73
1.10
0.15
2.3
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
77
0.78
0.15
2.3
2.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
14
122
1.15
0.14
6.4
4.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
9
107
0.84
0.13
1.1
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
37
396
0.93
0.13
2.5
2.6
ug/l
8.5
8.1
0.05
29
347
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
136
1328
1.03
0.10
3.1
2.7
u/l
54.6
58.4
0.56
125
1233
(3037522) Nuclear Ab [Titer] in Serum
51
487
1.05
0.10
1.5
1.3
titre
474.0
457.0
0.04
20
113
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
45
1.11
0.10
1.0
1.1
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
23
213
1.08
0.09
4.1
3.4
mmol/l
26.6
25.1
0.81
23
208
(21494890) Protein electrophoresis panel - 24 hour Urine
5
47
1.06
0.09
2.2
2.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
47
1.06
0.09
1.4
1.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
132
1291
1.03
0.09
2.6
2.2
u/l
141.5
279.4
1.49
126
1218
(4146454)
6
54
1.11
0.09
1.8
2.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
54
1.11
0.09
1.5
1.9
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
101
1037
0.97
0.09
4.5
3.2
—
—
—
0
0
(4306422)
6
55
1.09
0.09
1.0
1.3
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
25
234
1.07
0.08
3.5
2.9
e6/l
0.1
0.2
0.26
25
226
(40768793) Breast Pathology biopsy report
7
68
1.03
0.08
1.4
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
23
215
1.07
0.07
2.7
2.9
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
11
98
1.13
0.07
3.5
2.5
kpa
7.1
7.9
0.98
11
88
(3045424) Erythrocytes [Presence] in Urine
6
72
0.83
0.07
1.3
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
216
2132
1.02
0.07
2.7
2.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
8
75
1.07
0.07
2.3
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
8
75
1.07
0.07
2.3
1.5
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
9
88
1.02
0.07
1.7
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
91
0.88
0.07
1.1
1.5
—
—
—
0
0
(4010399)
30
315
0.95
0.06
1.3
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
13
119
1.10
0.06
2.1
2.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
47
456
1.03
0.05
2.0
2.3
nmol/l
15.3
13.5
0.95
41
412
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
10
91
1.10
0.04
1.1
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
48
493
0.97
0.04
1.7
1.9
%
1.7
1.6
0.23
40
419
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
147
1486
0.98
0.04
4.4
3.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
48
471
1.02
0.02
1.5
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
16
153
1.05
0.01
2.0
1.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
16
154
1.04
0.00
2.9
2.3
u/ml
0.5
0.4
—
10
84
(3037121) Protein [Mass/volume] in Urine
17
164
1.04
0.00
6.6
3.4
g/l
0.1
0.2
—
9
73
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
19
196
0.97
0.00
1.5
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
95
1.05
0.00
1.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
12
116
1.04
0.00
1.8
1.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
14
136
1.03
0.00
1.6
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
15
153
0.98
0.00
1.0
1.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
22
223
0.99
0.00
4.4
3.4
—
—
—
0
0
(3000492) Spirometry study
40
397
1.01
0.00
1.4
1.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
59
587
1.01
0.00
28.2
24.6
inr
1.3
1.3
—
6
76
(3048689) Calprotectin [Mass/mass] in Stool
40
398
1.01
0.00
1.5
2.5
ug/g
103.3
128.6
0.50
30
326
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
19.6
—
0
9
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
9
0.00
0.00
0.0
2.9
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
9
0.00
0.00
0.0
6.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.2
—
16.0
—
0
9
(3005033) Fetal Nuchal fold Thickness US
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
60
1.00
0.00
1.8
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
98.2
—
0
5
(3016330) Potassium [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
5
50
1.00
0.00
3.4
1.6
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
49
1.02
0.00
1.8
1.2
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
53
0.94
0.00
1.0
1.1
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
0
8
0.00
0.00
0.0
2.5
—
134.0
—
0
8
(3011544) Albumin [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
19.8
—
0
6
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
14.5
—
0
5
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
7
0.00
0.00
0.0
2.0
—
1.3
—
0
7
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
62
0.97
0.00
1.8
2.0
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
2.0
—
0
6
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
9
92
0.98
0.00
1.2
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
9
93
0.97
0.00
3.7
3.8
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
54
0.93
0.00
1.0
1.1
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
8.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
8.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
66
0.91
0.00
1.0
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
7
72
0.97
0.00
2.4
1.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
6.4
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
87.7
—
0
7
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
7
0.00
0.00
0.0
6.9
—
6.8
—
0
7
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
5
53
0.94
0.00
1.0
1.2
mmol/l
8.1
7.4
—
5
35
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_TONSIL – Malignant neoplasm of tonsil
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).